期刊文献+

抗肿瘤药物临床应用现状与研究进展 被引量:2

Evaluation of Clinical Efficacy and Review on Progress of Antineoplastic Drugs
下载PDF
导出
摘要 目的介绍各类抗肿瘤药物在肿瘤治疗中的研究进展及临床应用概况。方法综合国内外相关文献进行分析与评价。结果与结论目前抗肿瘤药物的发展进入了一个新的阶段,由天然药物的开发发展到了新靶点抗肿瘤药研究以及基因疗法等。随着临床应用的进一步扩展,肿瘤的药物治疗将在未来一段时间内得到更大发展。 Objectlve To introduce the present situation of clinical usage and research progress on different antineoplastic drugs in antineoplastic therapy. Methods To collect medical literatures in recent years all over the world for review. Results and Conclusion At present, the advance in antineoplastic drugs has already come to the new stage. It has developed from the exploitation of the natural drugs to new target drugs and gene therapy. With the enlargement of clinical usage,the tumor chemotherapy will get further advancements in the future.
作者 唐永刚
出处 《中国药业》 CAS 2008年第7期1-3,共3页 China Pharmaceuticals
关键词 肿瘤 抗肿瘤药物 临床应用 研究进展 tumor antineoplastic drugs clinical usage research progress
  • 相关文献

参考文献31

  • 1Liu JS, Kuo SR, Mchugh MM, et al. Adozelesin triggers DNA damage response pathways and arrests SV40 DNA replication though replication protein A inactivation[J]. J Biol Chem, 2000, 275(2): 1 391- 1 397.
  • 2Awada A, Punt C J, Piccat M J, et al. Phase I study of Carzelesin (U- 80, 244) given (4-weekly) by intravenous bolus schedule[J]. Br J Cancer, 1999, 79(9 - 10): 1 454 - 1 461.
  • 3Van Custsem E, Cunningham D, Maruun J, et al. Raltitrexed: current clinical status and future directions[J]. Ann Oncol, 2002, 13(4): 513- 522.
  • 4Diaz- Rubio E. New chemotherapeutic advances in pancreatic, coloreetal, and gastric cancers [ J ]. Oncologist, 2004, 9 (3): 282 - 294.
  • 5Vogelzang N J, Rusthoven J J, Symanowski J, et al. Phase Ⅲ study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma[J]. J Clin Oncol, 2003, 21(14): 2 636 -2 644.
  • 6傅卫国,杨东煜,颜天华,施产甫.抗肿瘤药物研究进展[J].南京军医学院学报,2000,22(3):176-178. 被引量:4
  • 7李荣华,张增叶,崔海靖.抗肿瘤药物的研究进展及临床应用评价[J].中国医院用药评价与分析,2004,4(1):16-19. 被引量:4
  • 8徐璐,姚明辉.肿瘤化疗的一些新进展[J].国外医药(合成药.生化药.制剂分册),2000,21(4):195-199. 被引量:6
  • 9Baker DE. Oxaliplatin: a new drug for the treatment of metastatic carcinoma of the conlon or rectum[J]. Rev Gastroenterol Disord, 2003, 3 (1):31 -38.
  • 10Countinho AK, Rocha LCM. Metastatic colorectal cancer: systemic treatment in the new millennium[J].Cancer Control, 2003, 10(3): 224- 238.

二级参考文献49

  • 1甄永苏,薛玉川,曹寿松,戚长菁,胡继兰,粟俭.核苷转运作为肿瘤化疗靶点的研究[J].中国肿瘤,1995,4(5):27-27. 被引量:1
  • 2李全,谢毓元.开发肿瘤化疗药的一些新途径[J].药学进展,1996,20(3):129-135. 被引量:2
  • 3李玉艳,李志裕,王华,尤启冬.拓扑异构酶与抗癌药[J].药学进展,1996,20(3):138-142. 被引量:8
  • 4印嘉骏.戊柔沙星治疗卡介菌无效的膀胱原位癌的疗效和安全性[J].国外医学:药学分册,2000,27(5):308-308.
  • 5[1]Herbst RS,Hess KR.Tran HT,et al.Phase I study of re combinant human endostatin in patients with advanced solid tumors.J Clin Onco,2002,20(18):3792~3803
  • 6[2]Thomas JP,Arzoomanian RZ,A1berti D,et al.Phase I pharmacokinetic and pharmacodynamic study of recombinant human endostatin in patients with advanced so1id tumors.J Clin Onco,2003,21(2):223~231
  • 7[3]Gingras D,Boivin D,Deckers C,et al.Neovasta tanovel antiangiogenic drug for cancer therapy.Anti Cancer Drugs,2003,l4(2):91~96
  • 8[4]Falardeau P,Champagne P, et al.Nevoastat,a natural lyoccurring multifunction,antiangiogenic drug in phase Ⅲ clinical trials.Semin Oncol,2001,28(6):620~625
  • 9[5]Cunningham D,Humblet Y,Siena S,et al. Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer.N Engl J Med,2004,351:337~345
  • 10[6]Fukuoka M,Yano S,Giaccone G,et al.Multi-institu tional randomised phase II trial of gefitinib for previously treated patients with advanced non sma1l cell lung cancer.J Clin Onco,2003,21:2237~2246

共引文献15

同被引文献32

引证文献2

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部